PRRT Neuroendocrine Tumor Response monitored using Circulating Transcript Analysis: The NETest

PURPOSE: Peptide receptor radionuclide therapy (PRRT) is effective for metastatic/inoperable neuroendocrine tumors (NETs). Imaging response assessment is usually efficient subsequent to treatment completion. Blood biomarkers such as PRRT Predictive Quotient (PPQ) and NETest are effective in real-tim...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Nucl Med Mol Imaging
Auteurs principaux: Bodei, Lisa, Kidd, Mark S., Singh, Aviral, van der Zwan, Wouter A., Severi, Stefano, Drozdov, Ignat A., Malczewska, Anna, Baum, Richard P., Kwekkeboom, Dik J, Paganelli, Giovanni, Krenning, Eric P., Modlin, Irvin M.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515632/
https://ncbi.nlm.nih.gov/pubmed/31838581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04601-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires